Increased Frequency of Infections at the End of the IVIG Dosing Cycle: Effect Characterization from Three Phase III StudiesMartin Bexon, O. Zenker, Jeffrey S. Baggish et al.|Journal of Allergy and Clinical Immunology|2012Cited by 4